Clinical Trial Update: Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients. [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on the evaluation of HB0043 for efficacy, safety, and tolerability in patients with Hidradenitis Suppurativa across Phase 1 a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• HB0043

Snippet

Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd. | Conditions: Hidradenitis Suppurativa | Phase 1, Phase 2 | Status: RECRUITING